multikinase inhibitors

Related by string. multi kinase inhibitor * : multikinase inhibitor / Inhibitor . Inhibitors : proton pump inhibitors . proton pump inhibitors PPIs . small molecule inhibitor . proton pump inhibitor PPI . inhibitors . Proton Pump Inhibitors PPIs . ACE inhibitors . angiotensin converting enzyme inhibitors . selective serotonin reuptake inhibitors . HMG CoA reductase inhibitors * *

Related by context. Frequent words. (Click for all words.) 56 metastatic renal cell carcinoma 54 T DM1 54 bone metastasis 53 sorafenib 53 liver metastases 53 CA4P 53 adjuvant therapy 53 GVAX 53 metastatic tumors 53 nilotinib 52 HGS ETR1 52 dasatinib 52 renal cell carcinoma 52 trastuzumab 52 BCR ABL 52 pancreatic cancers 52 chemotherapeutic 51 AP# [003] 51 sarcomas 51 CaP 51 HER2 51 vandetanib 51 malignancies 51 castration resistant prostate cancer 51 chemotherapeutic agents 51 taxane 51 pharmacologic 50 taxanes 50 risk stratification 50 metastatic 50 hematological cancers 50 hepatocellular carcinoma 50 NSCLC 50 kinase inhibitor 50 breast tumors 50 metastatic colorectal cancer 50 sunitinib 50 hepatocellular carcinoma HCC 50 chemoradiation 50 cell lymphomas 50 EGFR 49 neuroendocrine tumors 49 erlotinib 49 cutaneous T cell 49 Vectibix 49 biomarkers 49 GIST 49 metastatic disease 49 chemotherapeutic agent 49 chronic lymphocytic leukemia CLL 49 prostate cancers 49 B CLL 49 bone metastases 49 gemcitabine 49 imetelstat 48 induce apoptosis 48 Satraplatin 48 therapies 48 hormone refractory prostate cancer 48 chemotherapy regimens 48 diagnostic assays 48 cetuximab 48 IMGN# 48 vinorelbine 48 prostate tumor 48 pharmacogenetic 48 follicular lymphoma 48 Azixa 48 genotypic 48 bortezomib 48 tumor recurrence 48 cytotoxic 48 tumors 48 TORISEL 47 solid tumors 47 docetaxel 47 HER2 positive 47 colorectal cancers 47 cisplatin 47 talactoferrin 47 factor receptor 47 lymphomas 47 refractory multiple myeloma 47 HER2 negative 47 ASA# 47 biomarker 47 hypercalcemia 47 mCRC 47 Atiprimod 47 prostate breast 47 gefitinib 46 disease modifying 46 tumor shrinkage 46 advanced NSCLC 46 carcinomas 46 HGF 46 resistant ovarian cancer 46 PCA3 46 metastatic prostate cancer 46 unresectable 46 clinically validated

Back to home page